We are live on ! Find out more
EBACU

European Biotech Acquisition Corp. Units
EBACU

Delisted

EBACU was delisted on the 2nd of March, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of EBACU yet.

EBACU Hedge Fund Activity: Q1 2023 in Review

0 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Units (EBACU) for Q1 2023, worth a combined $0 — down 100% from $8M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of EBACU and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Millennium Management, exiting entirely with an estimated $2.01M sold.

  • 0 institutional investors held European Biotech Acquisition Corp. Units (EBACU) as of Q1 2023, down from 11 in Q4 2022.
  • Funds reported $0 of European Biotech Acquisition Corp. Units stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new European Biotech Acquisition Corp. Units positions in Q1 2023 and 11 closed out, a net change of -11 holders.
  • The largest European Biotech Acquisition Corp. Units seller in Q1 2023 was Millennium Management, an estimated $2.01M sold.

Based on aggregated 13F filings for Q1 2023.